Surgical techniques for shoulder osteoarthritis treatment
Official title: Comparison of Shoulder Arthroplasty Techniques in the Treatment of Glenohumeral Osteoarthritis: Protocol
Run by Ottawa Hospital Research Institute · NCT02966886 · Data updated 2026-11-12
This study is testing different surgical methods for treating shoulder osteoarthritis to see which one helps patients feel better and improves their quality of life after surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 216 (estimated) |
| Sponsor | Ottawa Hospital Research Institute Academic / other |
| Locations | 1 site (Ottawa, Ontario) |
| Status | Recruiting |
| Started | April 23, 2017 |
| Main results expected | December 2027 |
| Study ends | December 2028 |
| Registry record updated | April 30, 2024 |
| Trial ID | NCT02966886 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men and women of any age with advanced osteoarthritis of the glenohumeral joint who have not responded to standard non-surgical management.
✕Probably not a fit
Patients with mild osteoarthritis or those who have not yet attempted non-surgical management may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates different surgical techniques for treating osteoarthritis of the shoulder, specifically focusing on total shoulder arthroplasty (TSA). Patients with varying degrees of glenoid retroversion will be randomly assigned to receive either TSA with eccentric glenoid reaming, augmented glenoid component implantation, or posterior glenoid bone grafting. The primary objective is to assess patient outcomes using the Western Ontario Osteoarthritis of the Shoulder Index (WOOS) score at multiple post-operative intervals. Secondary objectives include evaluating component survivorship and quality of life improvements through various assessment tools over a two-year period.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced complications for patients undergoing shoulder arthroplasty.
How similar studies have gone: Other studies have shown promising results with similar surgical approaches, indicating potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patient Population The target population is both men and women of any age with advanced osteoarthritis of the glenohumeral joint who are considered by the treating surgeon to be a candidate for shoulder replacement. The type of arthritic process will not be considered a deciding factor. The arthritis must be amenable to treatment using either a humeral head replacement (stemmed or stem-less), or a standard total shoulder replacement. Inclusion Criteria 1. Patients who have failed standard non-surgical management of their shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as: 1. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs 2. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.) 3. Activity modification 2. Patients will present with a glenoid retroversion between 10-26 degrees. 3. Imaging, and intra-operative findings confirming advanced humeral head cartilage loss, with or without glenoid cartilage loss. 4. Age 18 years or older Exclusion Criteria 1. \< 10 degrees / \> 27 degrees of glenoid retroversion 2. Active joint or systemic infection 3. Rotator cuff arthropathy 4. Significant muscle paralysis 5. Charcot's arthropathy 6. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk) 7. Unable to understand the consent form/process 8. Pregnancy 9. Psychiatric illness that precludes informed consent 10. Unwilling to be followed for the duration of the study 11. Retroversion cannot be surgically corrected to within 10 degrees of neutral 12. History of previous shoulder surgery on affected side 13. Rheumatoid arthritis in the affected shoulder
Where it's running
-
The Ottawa Hospital
Ottawa, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Peter Lapner, MD — The Ottawa Hospital
- Study coordinator: Peter Lapner, MD
- Email: plapner@toh.ca
- Phone: 613-737-8899
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diaphragm-sparing regional anesthesia for shoulder surgery
This study tests whether a suprascapular and infraclavicular nerve block can provide good shoulder surgery pain relief without causing diaphragm problems, compared with the standard interscalene block, in older adults.
-
Lengthening a tendon to reduce shoulder pain after surgery
This study is testing if lengthening a tendon during shoulder surgery can help reduce pain in patients one year after their operation.
-
National Registry for Artery Embolization to Treat Chronic Pain
This study is testing if a procedure that blocks blood flow to painful areas can help people with chronic pain from osteoarthritis and other conditions feel better.
-
Registry to evaluate outcomes of FX Shoulder replacement devices
This study is setting up a registry to see how well FX Shoulder replacement devices work for patients after their surgeries over the next few years.
-
Evaluating outcomes of FX Shoulder Solutions implants for shoulder conditions
This study is testing how well FX Shoulder Solutions implants work for people who have had shoulder replacement surgeries to see if they help patients recover safely and effectively.
-
Comparing two shoulder surgeries for older patients with osteoarthritis
This study is testing which shoulder surgery works better for older patients with severe arthritis: a total shoulder replacement or a reverse shoulder replacement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.